Covid’s latest surge, Alnylam at the FDA, & the end of an era

What does Covid-19 have in store for the winter? When are good data not good enough? And how many would-be Wegovys are there?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Helen Branswell joins us to discuss the state of the Covid-19 pandemic heading into the fall and the rollout of boosters shots aimed at the latest viral variants. We also discuss the latest news in the life sciences, including an IPO implosion, a debate at the FDA, and the ups and downs of a career in biotech.

For more on what we cover, here’s the latest on booster shots; here’s more on Covid-19 in 2023; here’s the news on Alnylam Pharmaceuticals; here’s more on 2Seventy Bio; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Enthea Reports Clinical Results from First Year of Psychedelic Healthcare Benefit for Employees of Leading California-Based Soap Company | Psychedelic Invest

Enthea, the first and only licensed provider of health insurance benefits to cover psychedelic-assisted therapies, today released their one-year results from the benefit program it

August 11, 2023

Fragmented sleep in midlife linked to poorer cognitive function a decade later

People who have more disrupted sleep in their 30s and 40s may be more likely to have memory and thinking problems a decade later, according

January 4, 2024

Understanding the link between high-fat diets, insulin resistance, and diabetic heart disease

The relationship between a high-fat diet and increased risk of Type 2 diabetes and heart disease is well-known. But what is the connection and how

May 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.